#DCOY hashtag - Bluesky

3 weeks ago

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform Decoy Therapeutics (Nasdaq: DCOY) announced a strategic partnership with Quantori, supported by funding from Google Cloud, to build a Google Cloud-native, AI-driven peptide design and molecular simulation platform.The production-grade, GPU-accelerated platform will integrate folding models, molecular dynamics, and Decoy's IMP³ACT engine, targeting a ~25- to 100-fold increase in computational throughput to accelerate antiviral peptide discovery.

#DCOY Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform

www.stocktitan.net/news/DCOY/decoy-therapeu...

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

Decoy Therapeutics Plans a Reverse Stock Split to Comply with Nasdaq Listing Rule Decoy Therapeutics Inc. announces a 1-for-12 reverse stock split, aiming for compliance with Nasdaq’s minimum bid price requirement.

Decoy Therapeutics Plans a Reverse Stock Split to Comply with Nasdaq Listing Rule #USA #Cambridge #Biopharmaceutical #Decoy_Therapeutics #DCOY

0 0 0 0

StockTitan

@stocktitan.net

1 month ago

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split Decoy Therapeutics (NASDAQ: DCOY) will effect a 1-for-12 reverse stock split at 5:00 p.m. ET on March 6, 2026, with split-adjusted trading beginning March 9, 2026 under CUSIP 79400X602.The split reduces outstanding shares from ~6.38 million to ~532,000 and is intended to help Decoy regain compliance with Nasdaq's $1.00 minimum closing bid requirement. Outstanding options, warrants, and plan reserves will be adjusted and fractional shares will be paid in cash.

#DCOY Decoy Therapeutics Announces 1-for-12 Reverse Stock Split

www.stocktitan.net/news/DCOY/decoy-therapeu...

0 0 0 0

PRISM MarketView

@prismmarketview.bsky.social

2 months ago

PRISM Morning Movers
Premarket Gainers:
AlphaTON Capital ( #ATON) up 141%
Ambitions Enterprise Management Co. ( #AHMA) up 138%
Decoy Therapeutics ( #DCOY) up 90%
Beyond Air, Inc. ( #XAIR) up 46%

Premarket Decliners:
Signing Day Sports ( #SGN) down -33%
Travere Therapeutics ( #TVTX) down -31%

0 0 0 0

StockTitan

@stocktitan.net

2 months ago

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform Decoy Therapeutics (Nasdaq: DCOY) announced a Global Access Commitment Agreement with the Gates Foundation to fund development of a globally accessible, scalable peptide-conjugate manufacturing platform for antiviral therapeutics. The platform will be validated using Decoy's intranasal pan-coronavirus fusion inhibitor and built with U.S. and European contract manufacturers to enable rapid scale-up on standard peptide-synthesis machinery. Decoy expects to advance its lead pan-coronavirus antiviral to an IND filing within 12 months and progress programs for broad-acting flu/COVID-19/RSV antivirals and a peptide drug conjugate for GI cancers.

#DCOY Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform

www.stocktitan.net/news/DCOY/decoy-therapeu...

0 0 0 0